Hwang GS - Search Results

1

The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society.

Jung BC, Kim NH, Nam GB, Park HW, On YK, Lee YS, Lim HE, Joung B, Cha TJ, Hwang GS, Oh S, Kim JS. Jung BC, et al. Among authors: hwang gs. Korean Circ J. 2015 Jan;45(1):9-19. doi: 10.4070/kcj.2015.45.1.9. Epub 2015 Jan 26. Korean Circ J. 2015. PMID: 25653698 Free PMC article. Review.

2

Superiority of biphasic over monophasic defibrillation shocks is attributable to less intracellular calcium transient heterogeneity.

Hwang GS, Tang L, Joung B, Morita N, Hayashi H, Karagueuzian HS, Weiss JN, Lin SF, Chen PS. Hwang GS, et al. J Am Coll Cardiol. 2008 Sep 2;52(10):828-35. doi: 10.1016/j.jacc.2008.05.040. J Am Coll Cardiol. 2008. PMID: 18755345 Free PMC article.

3

Quality of Anticoagulation and Treatment Satisfaction in Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonist: Result from the KORean Atrial Fibrillation Investigation II.

Oh S, Kim JS, Oh YS, Shin DG, Pak HN, Hwang GS, Choi KJ, Kim JB, Lee MY, Park HW, Kim DK, Jin ES, Park J, Oh IY, Shin DH, Park HS, Kim JH, Kim NH, Ahn MS, Seo BJ, Kim YJ, Kang S, Lee J, Kim YH. Oh S, et al. Among authors: hwang gs. J Korean Med Sci. 2018 Nov 21;33(49):e323. doi: 10.3346/jkms.2018.33.e323. eCollection 2018 Dec 3. J Korean Med Sci. 2018. PMID: 30505257 Free PMC article.

4

Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from KORAFII registry.

Park HS, Kim YH, Kim JS, Oh YS, Shin DG, Pak HN, Hwang GS, Choi KJ, Oh S, Kim JB, Lee MY, Park HW, Kim DK, Jin ES, Park JS, Oh IY, Shin DH, Park HS, Kim JH, Kim NH, Ahn MS, Seo BJ, Kim YJ, Kang S, Lee J. Park HS, et al. Among authors: hwang gs. J Arrhythm. 2019 Jun 17;35(4):593-601. doi: 10.1002/joa3.12183. eCollection 2019 Aug. J Arrhythm. 2019. PMID: 31410229 Free PMC article.

5

Anticoagulant selection in relation to the SAMe-TT₂R₂ score in patients with atrial fibrillation: The GLORIA-AF registry.

Ntaios G, Huisman MV, Diener HC, Halperin JL, Teutsch C, Marler S, Gurusamy VK, Thompson M, Lip GYH, Olshansky B; GLORIA-AF Investigators. Ntaios G, et al. Hellenic J Cardiol. 2021 Mar-Apr;62(2):152-157. doi: 10.1016/j.hjc.2020.11.009. Epub 2020 Dec 15. Hellenic J Cardiol. 2021. PMID: 33338644 Free article. Clinical Trial.

6

Long-term evaluation of sensing variability of a floating atrial dipole in a single‑lead defibrillator: The mechanistic basis of long-term stability of amplified atrial electrogram.

Gwag HB, Lee SH, Kim JS, Park KM, On YK, Hwang GS, Park SW, Lee SH, Park SJ. Gwag HB, et al. Among authors: hwang gs. Int J Cardiol. 2021 Aug 1;336:67-72. doi: 10.1016/j.ijcard.2021.05.024. Epub 2021 May 13. Int J Cardiol. 2021. PMID: 33992702

7

Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data.

Pope MK, Hall TS, Schirripa V, Radic P, Virdone S, Pieper KS, Le Heuzey JY, Jansky P, Fitzmaurice DA, Cappato R, Atar D, Camm AJ, Kakkar AK; GARFIELD-AF investigators. Pope MK, et al. BMJ. 2021 Oct 27;375:e066450. doi: 10.1136/bmj-2021-066450. BMJ. 2021. PMID: 34706884 Free PMC article.

8

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.

Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Marler S, Gurusamy VK, Huisman MV; GLORIA-AF Investigators. Lip GYH, et al. Clin Res Cardiol. 2022 May;111(5):560-573. doi: 10.1007/s00392-022-01996-2. Epub 2022 Mar 16. Clin Res Cardiol. 2022. PMID: 35294625 Free PMC article.

9

Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry.

Lip GYH, Kotalczyk A, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Marler S, Gurusamy VK, Huisman MV; GLORIA-AF Investigators. Lip GYH, et al. Clin Res Cardiol. 2022 May;111(5):593. doi: 10.1007/s00392-022-02021-2. Clin Res Cardiol. 2022. PMID: 35384487 Free PMC article. No abstract available.

10

GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide.

Haas S, Camm JA, Harald D, Steffel J, Virdone S, Pieper K, Brodmann M, Schellong S, Misselwitz F, Kayani G, Kakkar AK; GARFIELD-AF Investigators. Haas S, et al. Clin Res Cardiol. 2023 Jun;112(6):759-771. doi: 10.1007/s00392-022-02079-y. Epub 2022 Sep 12. Clin Res Cardiol. 2023. PMID: 36094573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

606 results

Search Page